Kaitlyn D’Onofrio

DocwireNews

A recent cohort study found that lupus nephritis patients with end-stage renal disease (LN-ESRD) may significantly decrease their mortality risk by undergoing a renal transplant.The study consisted of data from the United States Renal Data System on LN-ESRD patients who were put on a waitlist for a renal transplant. Primary outcomes were all-cause and cause-specific mortality. Researchers calculated hazard ratios (HRs) using time-dependent Cox regression analysis.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Learn more about <a href="https://twitter.com/hashtag/KidneyTransplants?src=hash&amp;ref_src=twsrc%5Etfw">#KidneyTransplants</a> in patients with Lupus Nephritis in the latest <a href="https://twitter.com/hashtag/AnnalsPatientSummary?src=hash&amp;ref_src=twsrc%5Etfw">#AnnalsPatientSummary</a>: <a href="https://t.co/zfRO0bbLbj">https://t.co/zfRO0bbLbj</a>. <a href="https://t.co/GX8bp7FJNb">pic.twitter.com/GX8bp7FJNb</a>
&mdash; Annals of Int Med (@AnnalsofIM) <a href="https://twitter.com/AnnalsofIM/status/1088451649364885505?ref_src=twsrc%5Etfw">January 24, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>A total of 9,659 LN-ESRD patients were put on a renal transplant waitlist during the study period; 59% (n = 5,738) had a transplant. Waitlisted patients who underwent transplant had a lower all-cause morality risk (adjusted HR, 0.30 [95% CI, 0.27 to 0.33]). Cause-specific mortality adjusted HRs were as follows: cardiovascular disease, 0.26 (CI, 0.23 to 0.30); coronary heart disease, 0.30 (CI, 0.19 to 0.48); infection, 0.41 (CI, 0.32 to 0.52); and sepsis, 0.41 (CI, 0.31 to 0.53).https://twitter.com/DrJackieVolk/status/1087802244911771648One of the study&rsquo;s limitations is that other factors not measured by the researchers could be impacting the results; still, they wrote, &ldquo;the E-value analysis suggested robustness of the results.&rdquo;A previous <a href="https://www.ncbi.nlm.nih.gov/pubmed/28420067">study</a> also found good outcomes for LN-ESRD patients, specifically in a Latin American cohort. Researchers evaluated data from 65 kidney transplants in LN-ESRD patients; survival at one, 10, and 15 years was 98% (P = 0.99). Graft survival rates were 92% at one year, 83% at five years, and 71% at 15 years. Two (3.1%) patients experienced recurrent disease, and one patient diagnosed with recurrent LN died from an infection. When controlling for age and sex, survival rates were still 98% after 15 years; when controlling for donor, five-year survival was 100% and 15-year survival was 98%. Graft survival rates in age- and sex- controlled analysis were 90% at one year, 84% at five years, and 64% at 15 years, and in donor-controlled analysis for the same time period were 89%, 86%, and 79%, respectively (P = 0.7718).https://twitter.com/Lupusreference/status/1087961634352578561Researchers for the present study wrote of their findings, &ldquo;Renal transplant was associated with a survival benefit, primarily due to reduced deaths from cardiovascular disease and infection. The findings highlight the benefit of timely referral for transplant to improve outcomes in this population.&rdquo;<a href="https://proddocwire.wpengine.com/docwire-pick/lupus-nephritis-renal-disease/">Lupus Nephritis in End-stage Renal Disease Patients Declines</a><a href="https://proddocwire.wpengine.com/docwire-pick/voclosporin-lupus-nephritis-patients/">Voclosporin Add-on May Benefit Lupus Nephritis Patients</a><a href="https://proddocwire.wpengine.com/abstracts/mycophenolate-mofetil-versus-intravenous/">Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis</a><a href="https://proddocwire.wpengine.com/abstracts/rheumatology-abstracts/japanese-patients-lupus-nephritis/">Remission of proteinuria under therapeutic intervention and the renal outcomes in Japanese patients with lupus nephritis class III and IV</a>Source:<a href="https://annals.org/aim/article-abstract/2722549/renal-transplantation-survival-among-patients-lupus-nephritis-cohort-study"> Annals of Internal Medicine</a>

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Lupus Nephritis Patients with End-stage Renal Disease Benefit from Transplant

End-Stage Renal Disease

A recent cohort study found that lupus nephritis patients with end-stage renal disease (LN-ESRD) may significantly decrease their mortality risk by undergoing a renal ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe